Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.
Read More…
Industry, Sector and Symbol
Industry Patent owners & lessors
Sub-IndustryElectronic Components
SectorConsumer Discretionary
Phone415-558-0200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.17 billion
Profitability
Miscellaneous
Employees2,151
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable
Dolby Laboratories (NYSE:DLB) Frequently Asked Questions
What is Dolby Laboratories' stock symbol?
Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."
How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?
Dolby Laboratories announced a quarterly dividend on Thursday, August 1st. Investors of record on Monday, August 12th will be paid a dividend of $0.19 per share on Tuesday, August 20th. This represents a $0.76 annualized dividend and a yield of 1.18%. The ex-dividend date is Friday, August 9th. View Dolby Laboratories' Dividend History.
How were Dolby Laboratories' earnings last quarter?
Dolby Laboratories, Inc. (NYSE:DLB) announced its quarterly earnings results on Thursday, August, 1st. The electronics maker reported $0.38 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.11. The electronics maker earned $302.16 million during the quarter, compared to the consensus estimate of $305.29 million. Dolby Laboratories had a net margin of 21.64% and a return on equity of 9.00%. Dolby Laboratories's revenue was up 40.7% compared to the same quarter last year. During the same period last year, the company earned $0.18 earnings per share. View Dolby Laboratories' Earnings History.
When is Dolby Laboratories' next earnings date?
What guidance has Dolby Laboratories issued on next quarter's earnings?
Dolby Laboratories issued an update on its fourth quarter earnings guidance on Thursday, August, 1st. The company provided earnings per share guidance of $0.62-0.68 for the period, compared to the Thomson Reuters consensus estimate of $0.77. The company issued revenue guidance of $288-308 million, compared to the consensus revenue estimate of $317.28 million.
What price target have analysts set for DLB?
5 analysts have issued 12 month price objectives for Dolby Laboratories' stock. Their predictions range from $73.00 to $85.00. On average, they expect Dolby Laboratories' stock price to reach $79.33 in the next year. This suggests a possible upside of 23.1% from the stock's current price. View Analyst Price Targets for Dolby Laboratories.
What is the consensus analysts' recommendation for Dolby Laboratories?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dolby Laboratories.
What are Wall Street analysts saying about Dolby Laboratories stock?
Here are some recent quotes from research analysts about Dolby Laboratories stock:
- 1. According to Zacks Investment Research, "Dolby reported solid second-quarter fiscal 2019 results, wherein both the bottom line and the top line increased year over year. Impressive market traction of Dolby Cinema technology is proving to be a major profit churner for Dolby. Moreover, the company believes that surging demand for premium viewing experiences will fuel growth for Dolby Cinema over the long haul. The company’s growth strategy stands on three pillars — advancing the science of sight and sound, providing creative solutions and delivering superior experiences. Successful execution in each of these areas has led to healthy growth over the past quarters. Increasing content and devices in Dolby Vision and Dolby Atmos, coupled with growth in footprint of Dolby Cinema should drive business. The stock has outperformed the industry in the past year on average. However, stiff competition and fluctuation of cinema product sales pose threats to the company’s margin." (5/3/2019)
- 2. Barrington Research analysts commented, "We continue our OUTPERFORM investment rating on DLB and $85 price target: While the favorable financial impact from the rollout of new technologies continues to evolve, we feel the benefits from some of them are becoming increasingly meaningful. The company’s $0.76 annual dividend provides a yield of 1.2%. The company also is active in repurchasing its shares, with over $400 million in authorization currently remaining. Management has noted that monetization benefits from its cinema sector efforts remain in early stages in terms of financial metrics. However, excitement over the early success of these initiatives has created a more optimistic view of Dolby’s potential to create renewed corporate momentum as management continues to target a return to double-digit growth. Laboratories, Inc." (1/31/2019)
Has Dolby Laboratories been receiving favorable news coverage?
Media coverage about DLB stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dolby Laboratories earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the electronics maker a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Dolby Laboratories.
Are investors shorting Dolby Laboratories?
Dolby Laboratories saw a decline in short interest in September. As of September 30th, there was short interest totalling 1,020,000 shares, a decline of 35.8% from the August 30th total of 1,590,000 shares. Based on an average daily volume of 408,800 shares, the days-to-cover ratio is currently 2.5 days. Currently, 1.6% of the shares of the company are short sold. View Dolby Laboratories' Current Options Chain.
Who are some of Dolby Laboratories' key competitors?
What other stocks do shareholders of Dolby Laboratories own?
Who are Dolby Laboratories' key executives?
Dolby Laboratories' management team includes the folowing people:
- Mr. Kevin J. Yeaman, Pres, CEO & Director (Age 53)
- Mr. Lewis Chew, Principal Financial Officer (Age 56)
- Mr. Andy Sherman, Exec. VP, Gen. Counsel & Corp. Sec. (Age 52)
- Mr. Todd Pendleton, Sr. VP & Chief Marketing Officer (Age 47)
- Mr. Giles Baker, Sr. VP of Consumer Entertainment (Age 43)
Who are Dolby Laboratories' major shareholders?
Dolby Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional investors include Diversified Investment Strategies LLC (0.08%), Envestnet Asset Management Inc. (0.08%), Patten & Patten Inc. TN (0.05%), Denali Advisors LLC (0.04%), Brinker Capital Inc. (0.03%) and Cardinal Capital Management (0.03%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher, Ryan Nicholson and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.
Which major investors are selling Dolby Laboratories stock?
DLB stock was sold by a variety of institutional investors in the last quarter, including Cardinal Capital Management, Signaturefd LLC, Arden Trust Co, Strs Ohio and Diversified Investment Strategies LLC. Company insiders that have sold Dolby Laboratories company stock in the last year include Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher and Ryan Nicholson. View Insider Buying and Selling for Dolby Laboratories.
Which major investors are buying Dolby Laboratories stock?
DLB stock was bought by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Patten & Patten Inc. TN, Denali Advisors LLC, Meeder Asset Management Inc., Envestnet Asset Management Inc., Zeke Capital Advisors LLC, Zurcher Kantonalbank Zurich Cantonalbank and Brinker Capital Inc.. View Insider Buying and Selling for Dolby Laboratories.
How do I buy shares of Dolby Laboratories?
Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Dolby Laboratories' stock price today?
One share of DLB stock can currently be purchased for approximately $64.45.
How big of a company is Dolby Laboratories?
Dolby Laboratories has a market capitalization of $6.49 billion and generates $1.17 billion in revenue each year. The electronics maker earns $122.24 million in net income (profit) each year or $2.40 on an earnings per share basis. Dolby Laboratories employs 2,151 workers across the globe.View Additional Information About Dolby Laboratories.
What is Dolby Laboratories' official website?
How can I contact Dolby Laboratories?
Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]
MarketBeat Community Rating for Dolby Laboratories (NYSE DLB)
MarketBeat's community ratings are surveys of what our community members think about Dolby Laboratories and other stocks. Vote "Outperform" if you believe DLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
